Literature DB >> 7622216

Shigella infection induces cellular activation of T and B cells and distinct species-related changes in peripheral blood lymphocyte subsets during the course of the disease.

D Islam1, P K Bardhan, A A Lindberg, B Christensson.   

Abstract

Immunophenotypic changes in peripheral blood lymphocytes (T, B, and NK cells) in patients during shigellosis was characterized by using triple-color flow cytometry. Eleven Shigella dysenteriae 1-infected adult patients (SDIP), 11 Shigella flexneri-infected adult patients (SFIP), 15 age- and sex-matched healthy controls from Bangladesh (C-B), and 15 healthy volunteers from Sweden (V-S) were studied. In SDIP and SFIP, a significant increase in the CD45RO+ cells in both CD4+ and CD8+ T cells were seen. We found evidence for sequential T-cell activation, as shown by increased proportions of CD25 and CD4+ cells; HLA-DR and CD38 on CD8+ cells, and CD54 on CD4+ and CD8+ cells. We found differences in the lymphocyte activation and subset patterns related to the infecting Shigella species. Thus, a decrease in CD45 expression was seen in SFIP; this decrease progressed further during the disease. The proportions of NK cells (CD56+ cells) and CD3- CD8+ cells out of the total CD8+ cells were increased in SFIP but not in SDIP. The CD3+ CD8+ CD57+ T-cell subset was significantly lower in SDIP than in C-B. The proportion of B-lymphocyte-expressing activation markers CD80 and CD23 was higher in patients than in C-B. There was a significant increase in the proportion of CD4+ T cells and a significant decrease in the percentages of total B cells, the CD3+ CD8+ CD57+ T-cell subset, and the CD56+ CD16+ NK-cell subset for V-S compared with C-B. Our results indicate that distinct subset changes and activation patterns are elicited in SDIP compared with SFIP and also that the degree of activation is related to disease severity. In addition, a common sequence of cell activation was seen during the disease course. The difference in the subset patterns seen in C-B and V-S may be related to differences in the levels or spectra of infectious agents in the environment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7622216      PMCID: PMC173400          DOI: 10.1128/iai.63.8.2941-2949.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Identification of an inducible endothelial-leukocyte adhesion molecule.

Authors:  M P Bevilacqua; J S Pober; D L Mendrick; R S Cotran; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens.

Authors:  F Pallone; S Fais; O Squarcia; L Biancone; P Pozzilli; M Boirivant
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

3.  Utility of formaldehyde fixation for flow cytometry and inactivation of the AIDS associated retrovirus.

Authors:  J D Lifson; D T Sasaki; E G Engleman
Journal:  J Immunol Methods       Date:  1986-01-22       Impact factor: 2.303

Review 4.  The role of natural killer cells in innate resistance to infection.

Authors:  G J Bancroft
Journal:  Curr Opin Immunol       Date:  1993-08       Impact factor: 7.486

5.  Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1.

Authors:  M H Munshi; D A Sack; K Haider; Z U Ahmed; M M Rahaman; M G Morshed
Journal:  Lancet       Date:  1987-08-22       Impact factor: 79.321

6.  Natural cytotoxic effector cell activity against Shigella flexneri-infected HeLa cells.

Authors:  G R Klimpel; D W Niesel; K D Klimpel
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

7.  Paraformaldehyde fixation of hematopoietic cells for quantitative flow cytometry (FACS) analysis.

Authors:  L L Lanier; N L Warner
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

8.  A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody.

Authors:  C Morimoto; A D Steinberg; N L Letvin; M Hagan; T Takeuchi; J Daley; H Levine; S F Schlossman
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

9.  Lymphocyte activation in rheumatoid arthritis synovial fluid in vivo.

Authors:  Y Konttinen; V Bergroth; P Nykänen
Journal:  Scand J Immunol       Date:  1985-11       Impact factor: 3.487

10.  Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody.

Authors:  C Morimoto; D A Hafler; H L Weiner; N L Letvin; M Hagan; J Daley; S F Schlossman
Journal:  N Engl J Med       Date:  1987-01-08       Impact factor: 91.245

View more
  16 in total

Review 1.  Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Authors:  Myron M Levine; Karen L Kotloff; Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

2.  Case series study of traveler's diarrhea in U.S. military personnel at Incirlik Air Base, Turkey.

Authors:  C K Porter; H El Mohammady; S Baqar; D M Rockabrand; S D Putnam; D R Tribble; M S Riddle; R W Frenck; P Rozmajzl; E Kilbane; A Fox; R Ruck; M Lim; Y J Johnston; E Murphy; J W Sanders
Journal:  Clin Vaccine Immunol       Date:  2008-10-08

3.  Adaptive immune responses during Shigella dysenteriae type 1 infection: an in vitro stimulation with 57 kDa major antigenic OMP in the presence of anti-CD3 antibody.

Authors:  Ashim Kumar Bagchi; Ajoy Kumar Sinha; Rushita Adhikari; Joydeep Mukherjee
Journal:  Mol Cell Biochem       Date:  2009-11-14       Impact factor: 3.396

Review 4.  Progress and pitfalls in Shigella vaccine research.

Authors:  Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein; Alessio Fasano; Karen L Kotloff; Myron M Levine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-19       Impact factor: 46.802

Review 5.  The pathogenesis of Shigella flexneri infection: lessons from in vitro and in vivo studies.

Authors:  D J Philpott; J D Edgeworth; P J Sansonetti
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

6.  Parameters underlying successful protection with live attenuated mutants in experimental shigellosis.

Authors:  M L Bernardini; J Arondel; I Martini; A Aidara; P J Sansonetti
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

7.  Selective deletion of CD8(+) cells upregulated by caspases-1 via IL-18 in mice immunized with major outer membrane protein of Shigella dysenteriae 1 following infection.

Authors:  Ashim Kumar Bagchi; Ajoy Kumar Sinha; Rushita Adhikari; Pradip Maiti; Joydeep Mukherjee; Arpita Panda; Dhira Rani Saha
Journal:  J Clin Immunol       Date:  2010-01-19       Impact factor: 8.317

8.  Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection.

Authors:  A Kalinkovich; Z Weisman; Z Greenberg; J Nahmias; S Eitan; M Stein; Z Bentwich
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

9.  Monocyte human leukocyte antigen-DR expression-a tool to distinguish intestinal bacterial infections from inflammatory bowel disease?

Authors:  Wolfgang Tillinger; Ruth Jilch; Thomas Waldhoer; Walter Reinisch; Wolfgang Junger
Journal:  Shock       Date:  2013-08       Impact factor: 3.454

10.  Analysis of T cell subsets present in the peripheral blood and synovial fluid of reactive arthritis patients.

Authors:  H Beacock-Sharp; J L Young; J S Gaston
Journal:  Ann Rheum Dis       Date:  1998-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.